OraSures OMNIgene-ORAL kit included in EUA granted to P23 labs for at-home collection of saliva samples for SARS-CoV-2 test
On May 22, 2020, OraSure Technologies announced that its OMNIgene-ORAL saliva collection device (OM-505) was included in the…
On May 22, 2020, OraSure Technologies announced that its OMNIgene-ORAL saliva collection device (OM-505) was included in the…
On May 21, 2020, the FDA posted list of antibody tests removed from the ‘notification list’ of tests…
On May 21, 2020, Abbott announced an interim analysis of an ongoing multi-site clinical study in urgent care…
On May 21, 2020, AstraZeneca announced it was advancing its response to address the unprecedented challenges of COVID-19,…
On May 21, 2020, bioMerieux announced the CE marking of VIDAS anti-SARS-CoV-2 serology tests to detect antibodies in…
On May 21, 2020, Innovation Pharma announced that in vitro research independently conducted at a U.S. Regional Biocontainment…
On May 21, 2020, ADMA Biologics announced it had commenced the collection of convalescent plasma through its wholly-owned…
On May 21 2020, Amarin announced support for a clinical trial to investigate the effects of icosapent ethyl…
On May 21, 2020, BioAegis Therapeutics announced that the National Institute of Health Clinical Center began measuring patient…
On May 21, 2020, Montefiore Health System and Albert Einstein College of Medicine were the first sites in…
On May 20, 2020, Mammoth Biosciences announced a collaboration with GSK Consumer Healthcare to develop an accurate, easy-to-use,…
On May 20, 2020, Kindred Biosciences announced it had entered into an agreement with Vaxart for the manufacture…
On May 20, 2020, Vaxart announced it had selected its lead COVID-19 vaccine candidate and had contracted with…
On May 20, 2020, BioSig Technologies and its subsidiary, ViralClear Pharmaceuticals, announced the closing of a $10.8 million…
On May 20, 2020, CHF Solutions announced a publication highlighting the use of ultrafiltration for fluid management of…
On May 20, 2020, Airway Therapeutics and Celonic Group announced a collaboration to produce the novel human recombinant…
On May 20, 2020, INOVIO announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA…
On May 20, 2020, Bharat Biotech and Thomas Jefferson University of Philadelphia announced an exclusive deal to develop…
On May 20, 2020, Diffusion Pharmaceuticals announced it had entered into an agreement with the Romanian National Institute…
On May 20, 2020, Atossa Therapeutics announced the successful results from in vitro testing of AT-H201, Atossaï¾’s proprietary…
On May 19, 2020, the University of Oxford announced the release of the T-SPOT Discovery SARS-CoV-2 test kit….
On May 19, 2020, the FDA announced an agreement with Aetion to collaborate on advanced analytical techniques to…
On May 19, 2020, a University of Southern California (USC) study reported results from the first phase of…
On May 19, 2020, in a study published in Cell Reports, researchers at the University of Hong Kong…
On May 19, 2020, Innovation Pharma announced that its anti-SARS-CoV-2 (COVID-19) drug candidate, Brilacidin, in an in vitro…
On May 19, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…
On May 19, 2020, Phlow, a U.S.-based, public benefit drug manufacturing corporation, received federal government funding of $354…
On May 19, 2020, CytoDyn announced it will be coordinating with the National Institution of Health of Mexico…
On May 18, 2020, with $9 million from the COVID-19 Therapeutics Accelerator, an international group of physicians and…
On May 18, 2020, NantKwest announced it had received authorization from the FDA for an Investigational New Drug…